Dr Bob on Nostr: Why Cigna is capping cost increases for pricey GLP-1 weight loss drugs The move — ...
Why Cigna is capping cost increases for pricey GLP-1 weight loss drugs
The move — the first of its kind — comes as PBMs continue to try to prove their value to clients, and shows how major players are shoring up to meet sky-high #GLP1 demand.
The insurer plans to cap annual price increases for the drugs, called GLP-1 receptor agonists, at 15% for employers and plans participating in a weight loss management program offered by its pharmacy benefit manager.
#obesity #weightloss #ozempic #wegovy #mounjaro #zepbound
https://www.healthcaredive.com/news/cigna-glp-1-cost-cap-employers-pbm/709597/
The move — the first of its kind — comes as PBMs continue to try to prove their value to clients, and shows how major players are shoring up to meet sky-high #GLP1 demand.
The insurer plans to cap annual price increases for the drugs, called GLP-1 receptor agonists, at 15% for employers and plans participating in a weight loss management program offered by its pharmacy benefit manager.
#obesity #weightloss #ozempic #wegovy #mounjaro #zepbound
https://www.healthcaredive.com/news/cigna-glp-1-cost-cap-employers-pbm/709597/